1Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of se- vere sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41 (2):580-637.
2Dandona P, Nix D, Wilson MF, et al. Procalcitonin inerease 'after endotoxin injection in normal subjeets[J]. J Clin En- docrinol Metab, 1994, 79(6):1605-1608.
3Groselj-Grene M, Ihan A, Pavcnik-Arnol M, et al. Neu- trophil and monocyte CD64 indexes, lipopolysaecharide- binding protein, procaleitoninand C-reaetive protein in sepsis of critically ill neonates and children[J]. Intensive Care Med, 2009, 35(11):1950-1958.
5Petrikkos GL, Christofilopoulou SA, Tentolouris NK, et al. Value of measuring serum procalcitonin, C-reactive pro- tein, and mannan antigens to distinguish fungal from bacte- rial infections[J]. Eur J Clin Microbiol Infect Dis, 2005, 24 (4):272-275.
7Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bactcremia caused by either gram negative or gram positive bacteria[J]. BMC Infect Dis, 2008, 8(1):1-8.
8Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study[J]. In- tensive Care Med, 2011, 37(5):796-800.
9Hillas G, Vassilakopoulos T, Plantza P, et al. C-reactive protein and procalcitonin as predictors of survival and sep- tic shock in ventilator-associated pneumonia[J]. Eur Respir J, 2010, 35(4):805-811.
10Tsalik EL, Jaggers LB, Gliekman SW, et al. Discriminative value of inflammatory biomarkers for suspected sepsis[J]. J Emerg Med, 2012, 43(1):97-106.
4Bone RC,Balk RA,Cerra FB. ACCP/SCCM definitions for sepsis and organ failure guidelines for the use of innovative therapies in sepsis[J]. Chest, 1992,101:1644- 1655.
5Joan M. The role of C reactive protein in the evaluation and management of infants with suspected sepsis[J].Adv Neonatal Care,2003,3(1):3 -13.
6Povoa P, Almeida E, Moreira P,et al. C-reactive protein as an in dicator of sepsis[J]. Intensive Care Med, 2008, 24: 1052-1056.
7Claeys R,Vinken S,Spapen H,etal. Plasma procalcitonin and C- reactive protein in acute septic shock: clinical and biological corerlates[J]. Crit Care Med, 2002,30(4) :757-762.
8Haweky PM. Mechanisms of resistance to antibiotics[J]. In tensiev Caer Med, 2000,26 : 9 -13.
9Groselj-Grenc M,Ihan A,Pavcnik-Arnol M,et al.Neutrophiland monocyte CD64indexes,lipopolysaccharide-binding pro-tein,procalcitonin and C-reactive protein in sepsis of criticallyill neonates and children[J].Intensive Care Med,2009,35(11):1950-1958.
10Schützle H,Forster J,Superti-Furga A,et al.Is serum procal-citonin a reliable diagnostic marker in children with acute re-spiratory tract infections A retrospective analysis[J].Eur JPediatr,2009,168(9):1117-1124.
3Limper M,de Kruif MD,Duits AJ,et al. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever[J]. J Infect, 2010,60(6):409-416.
4Matwiyoff GN,Prahl JD,Miller RJ,et al. Immune regulation of procalcitonin:a biomarker and mediator of infection [J]. Inflamm Res, 2012,61 (5) : 401-409.
5Assicot M,Gendrel D,Carsin H,et al. High serum procalcitonin concentrations in patients with sepsis and infection [J]. Lancet, 1993,341(8844) : 515-8.0.
6Leelerc F, Leteurtre S, Duhamel A, et al. Cumulative influence of organ dysfunctions and septic state on mortality of critically ill children [J ]. Am J Respir Crit Care Med, 2005,171 (4) :348- 453.
7da Silva ED, Koch NPC, Russo ZTM, et al. Risk factors for death in children and adolescents with cancer and sepsis/septic shock[J]. Pediatr Hematol Oncol,2008,30(7) :513-518.
8Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis [ J ]. Pediatr Crit Care Med, 2005,6 (3) : 3-5.
9Boussekey N, Leroy O, Georges H, et al. Diagnostic and prog- nostic values of admission procalcitonin levels in community- acquired pneumonia in an intensive care unit [J]. Infection, 2005,33(4) : 257-263.
10Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin eleva- tion in critically ill patients at the onset of bacteremia caused by either Gram-negative or Gram-positive bacteria [J]. BMC Infect Dis, 2008,8 : 38-38.
